Granules India Investor Relations Material
Latest events
Q1 25/26
Granules India
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Granules India Limited
Access all reports
Granules India Limited is a pharmaceutical company engaged in the manufacturing and distribution of active pharmaceutical ingredients (APIs), pharmaceutical formulations intermediates (PFIs), and finished dosage forms (FDFs). The company serves global pharmaceutical markets, supplying essential medicines across therapeutic categories such as pain management, cardiovascular, and anti-infectives. The company operates manufacturing facilities in India and internationally. It is headquartered in Hyderabad, India, and its shares are listed on the BSE.
Key slides for Granules India Limited
Q4 24/25
Granules India Limited
Q1 25/26
Granules India Limited
Latest articles
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
Ticker symbol
532482
Country
🇮🇳 India